| |
| |
|
| Insider
Information: |
Burbank Jeffrey H |
| Relationship: |
Director |
| City: |
Lawrence |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
47,471 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,097,530 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
47,471 |
|
|
| Total
Value |
$1,097,530 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Nxstage Medical, Inc. |
NXTM |
|
2019-02-21 |
0 |
|
0 |
Premium* |
|
|
Cryolife Inc |
CRY |
Director |
2024-05-30 |
47,471 |
2018-05-23 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
187 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 8 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NXTM |
Nxstage Medical, Inc. |
CEO |
• • – |
2014-07-25 |
4 |
OE |
$2.11 |
$1,473,998 |
D/D |
296,846 |
933,557 |
0 |
- |
|
| NXTM |
Nxstage Medical, Inc. |
Chief Executive Officer |
• • – |
2017-02-23 |
4 |
AS |
$28.97 |
$217,275 |
D/D |
(7,500) |
936,249 |
0 |
- |
|
| NXTM |
Nxstage Medical, Inc. |
CEO |
• • – |
2014-11-24 |
4 |
OE |
$14.44 |
$1,732,800 |
D/D |
120,000 |
936,481 |
0 |
- |
|
| NXTM |
Nxstage Medical, Inc. |
Chief Executive Officer |
• • – |
2017-04-20 |
4 |
AS |
$27.28 |
$81,840 |
D/D |
(3,000) |
939,086 |
0 |
- |
|
| NXTM |
Nxstage Medical, Inc. |
Chief Executive Officer |
• • – |
2017-04-19 |
4 |
AS |
$26.65 |
$79,950 |
D/D |
(3,000) |
942,086 |
0 |
- |
|
| NXTM |
Nxstage Medical, Inc. |
Chief Executive Officer |
• • – |
2017-02-22 |
4 |
AS |
$29.01 |
$217,575 |
D/D |
(7,500) |
943,749 |
0 |
- |
|
| NXTM |
Nxstage Medical, Inc. |
Chief Executive Officer |
• • – |
2017-03-22 |
4 |
AS |
$27.42 |
$82,260 |
D/D |
(3,000) |
945,086 |
0 |
- |
|
| NXTM |
Nxstage Medical, Inc. |
Chief Executive Officer |
• • – |
2017-03-21 |
4 |
AS |
$27.72 |
$83,160 |
D/D |
(3,000) |
948,086 |
0 |
- |
|
| NXTM |
Nxstage Medical, Inc. |
Chief Executive Officer |
• • – |
2017-03-03 |
4 |
D |
$28.31 |
$373,267 |
D/D |
(13,185) |
951,086 |
0 |
- |
|
| NXTM |
Nxstage Medical, Inc. |
Chief Executive Officer |
• • – |
2017-02-10 |
4 |
D |
$28.38 |
$1,406,371 |
D/D |
(49,555) |
951,249 |
0 |
- |
|
| NXTM |
Nxstage Medical, Inc. |
Chief Executive Officer |
• • – |
2017-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
28,022 |
964,271 |
0 |
- |
|
| NXTM |
Nxstage Medical, Inc. |
Chief Executive Officer |
• • – |
2017-02-10 |
4 |
OE |
$9.96 |
$1,406,301 |
D/D |
133,188 |
1,000,804 |
0 |
- |
|
187 Records found
|
|
Page 8 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
